ANDA 89628, held by Pharmachemie USA. Leucovorin Calcium.
As of Nov 16, 2026, ANDA 89628 (Leucovorin Calcium), held by Pharmachemie USA, was first approved by FDA on Apr 17, 1997, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 17, 1997 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Leucovorin CalciumEQ 50MG BASE/VIAL ยท injectable;injection | Leucovorin Calcium | Discontinued |
| Sep 15, 1998 | Supplement 1Manufacturing | Approved | None posted |
| May 6, 1998 | Supplement 3Labeling | Approved | None posted |
| Feb 24, 1998 | Supplement 2Labeling | Approved | None posted |
| Apr 17, 1997 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters